91ÖÆƬ³§

The global market for Iopamidol Injection was valued at US$ 876 million in the year 2023 and is projected to reach a revised size of US$ 999 million by 2030, growing at a CAGR of 1.9% during the forecast period.
Iopamidol injection is a non-ionic, water-soluble contrast agent commonly used in diagnostic imaging procedures such as computed tomography (CT) scans, angiography, and urography to improve the visibility of blood vessels, organs, and tissues by providing contrast enhancement for accurate visualization and interpretation of medical images.
Market Drivers:
Diagnostic Clarity: Iopamidol injection enhances the clarity and quality of diagnostic images by providing excellent contrast enhancement, tissue delineation, and visualization of anatomical structures, aiding healthcare professionals in making accurate diagnoses, treatment planning, and monitoring of medical conditions.
Renal Safety: With a lower risk of causing contrast-induced nephropathy (CIN) and renal injury compared to some other contrast agents, iopamidol is considered a safer option for patients with compromised renal function or those at higher risk of kidney complications following contrast-enhanced imaging studies.
Versatility in Imaging: Iopamidol injection is versatile and widely used in various radiological imaging modalities, including CT scans, angiography, urography, and vascular interventions, making it a preferred choice across medical specialties such as radiology, cardiology, interventional radiology, and urology for diagnostic and interventional procedures.
Patient Comfort: Continuous improvements in iopamidol formulations focus on enhancing patient comfort and safety during imaging procedures, with developments in low-osmolality contrast agents, reduced injection volumes, and improved tolerability contributing to a better overall patient experience in diagnostic imaging studies.
Technological Advancements: Ongoing research and development efforts aim to optimize the formulation of iopamidol injection, improve image acquisition protocols, and enhance imaging equipment capabilities to deliver high-quality diagnostic images with reduced artifacts, improved spatial resolution, and enhanced diagnostic information.
Market Challenges:
Cost Constraints: The cost of iopamidol injection and associated imaging procedures can be a significant factor affecting its adoption, accessibility, and affordability for healthcare facilities, patients, and healthcare systems, particularly in the context of budget constraints and reimbursement limitations.
Competitive Landscape: The contrast media market is competitive, with multiple manufacturers offering a range of contrast agents, including iopamidol, leading to pricing pressures, market saturation, and challenges in differentiating products based on efficacy, safety, and cost-effectiveness to gain market share.
Regulatory Compliance: Manufacturers of iopamidol injection must adhere to stringent regulatory requirements, quality standards, and safety guidelines for contrast media production, labeling, and distribution to ensure product quality, consistency, and compliance with regulatory approvals for market entry.
Patient Factors: Variability in patient factors such as allergies, renal function, comorbidities, and medication history can influence the choice of contrast agents, dosing considerations, and risk assessment for iopamidol injection, necessitating personalized approaches to patient care and contrast administration.
Adverse Events Management: Despite its favorable safety profile, iopamidol injection can still lead to adverse reactions such as hypersensitivity responses, nephrotoxicity, and rare but serious side effects, requiring vigilant monitoring, prompt recognition, and appropriate management of adverse events during and after imaging procedures.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Iopamidol Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Iopamidol Injection.
The Iopamidol Injection market size, estimations, and forecasts are provided in terms of sales volume (K L) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Iopamidol Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Iopamidol Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Bracco Imaging
Sanochemia
BeiLu Pharma
Segment by Type
9 g I/ 30 mL
11.1 g I/ 30 mL
Others
Segment by Application
Hospitals
Clinics
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Iopamidol Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Iopamidol Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report. 

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.